Cargando…
Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study
PURPOSE: Evidence for efficacy and safety lacks for long-term opioid therapy in patients with chronic non-cancer pain and adverse effects, including affection of cognitive function and quality of life, is of concern. We aimed to investigate cognitive function and health-related quality of life in pa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754260/ https://www.ncbi.nlm.nih.gov/pubmed/33363405 http://dx.doi.org/10.2147/JPR.S273025 |
_version_ | 1783626154185326592 |
---|---|
author | Laigaard, Jens Bache, Nina Stottmeier, Stefan Mathiesen, Ole Estrup, Stine |
author_facet | Laigaard, Jens Bache, Nina Stottmeier, Stefan Mathiesen, Ole Estrup, Stine |
author_sort | Laigaard, Jens |
collection | PubMed |
description | PURPOSE: Evidence for efficacy and safety lacks for long-term opioid therapy in patients with chronic non-cancer pain and adverse effects, including affection of cognitive function and quality of life, is of concern. We aimed to investigate cognitive function and health-related quality of life in patients with chronic non-cancer pain during opioid reduction. PATIENTS AND METHODS: At two multidisciplinary pain centers, all patients with planned opioid reduction were screened for eligibility. Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and Trail Making Test A and B. Health-related quality of life was assessed using Short Form-36 (SF36) and Hospital Anxiety and Depression Scale (HADS). RESULTS: We included 51 participants and 40 participants attended follow-up of median 254 (IQR 106–357) days. Baseline RBANS score was 82 (IQR 65–93) with reference population norm value of 100 (SD±15). Daily opioid consumption was reduced from median 80 (IQR 45–161) oral morphine milligram equivalents to 19 (IQR 0–60) mg. RBANS score estimate increased by 6.2 (95% CI 3.1–9.3, p=0.0004) points after tapering. No differences were observed for Trail Making Test times, HADS or SF36 scores. CONCLUSION: Generally, cognitive function showed minor improvement after opioid tapering with stationary health-related quality of life, depression and anxiety scores. The clinical significance is unclear, as no minimal clinically important difference in RBANS score is available. |
format | Online Article Text |
id | pubmed-7754260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-77542602020-12-23 Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study Laigaard, Jens Bache, Nina Stottmeier, Stefan Mathiesen, Ole Estrup, Stine J Pain Res Original Research PURPOSE: Evidence for efficacy and safety lacks for long-term opioid therapy in patients with chronic non-cancer pain and adverse effects, including affection of cognitive function and quality of life, is of concern. We aimed to investigate cognitive function and health-related quality of life in patients with chronic non-cancer pain during opioid reduction. PATIENTS AND METHODS: At two multidisciplinary pain centers, all patients with planned opioid reduction were screened for eligibility. Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and Trail Making Test A and B. Health-related quality of life was assessed using Short Form-36 (SF36) and Hospital Anxiety and Depression Scale (HADS). RESULTS: We included 51 participants and 40 participants attended follow-up of median 254 (IQR 106–357) days. Baseline RBANS score was 82 (IQR 65–93) with reference population norm value of 100 (SD±15). Daily opioid consumption was reduced from median 80 (IQR 45–161) oral morphine milligram equivalents to 19 (IQR 0–60) mg. RBANS score estimate increased by 6.2 (95% CI 3.1–9.3, p=0.0004) points after tapering. No differences were observed for Trail Making Test times, HADS or SF36 scores. CONCLUSION: Generally, cognitive function showed minor improvement after opioid tapering with stationary health-related quality of life, depression and anxiety scores. The clinical significance is unclear, as no minimal clinically important difference in RBANS score is available. Dove 2020-12-14 /pmc/articles/PMC7754260/ /pubmed/33363405 http://dx.doi.org/10.2147/JPR.S273025 Text en © 2020 Laigaard et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Laigaard, Jens Bache, Nina Stottmeier, Stefan Mathiesen, Ole Estrup, Stine Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study |
title | Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study |
title_full | Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study |
title_fullStr | Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study |
title_full_unstemmed | Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study |
title_short | Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study |
title_sort | cognitive function during opioid tapering in patients with chronic pain: a prospective cohort study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754260/ https://www.ncbi.nlm.nih.gov/pubmed/33363405 http://dx.doi.org/10.2147/JPR.S273025 |
work_keys_str_mv | AT laigaardjens cognitivefunctionduringopioidtaperinginpatientswithchronicpainaprospectivecohortstudy AT bachenina cognitivefunctionduringopioidtaperinginpatientswithchronicpainaprospectivecohortstudy AT stottmeierstefan cognitivefunctionduringopioidtaperinginpatientswithchronicpainaprospectivecohortstudy AT mathiesenole cognitivefunctionduringopioidtaperinginpatientswithchronicpainaprospectivecohortstudy AT estrupstine cognitivefunctionduringopioidtaperinginpatientswithchronicpainaprospectivecohortstudy |